“A Case Report on Prolonged Response With Trastuzumab Emtansine (T-DM1) in Recurrent Advance Breast Cancer Setting”. 2023. Journal of Cancer Research Updates 12 (December): 49-53. https://doi.org/10.30683/1929-2279.2023.12.9.